Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Alimentary Pharmacology & Therapeutics
|
April 19, 2007
Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan
J-F Huang, M-L Yu, C-M Lee, et al.
Journal of Medical Virology
|
August 16, 2001
Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan
M L Yu, W L Chuang, S C Chen, et al.
The Kaohsiung Journal of Medical Sciences
|
March 29, 2001
The epidemiology of TT virus (TTV) infection in a hepatitis C and B virus hyperendemic area of southern Taiwan
C Y Dai, M L Yu, W L Chuang, et al.
International Journal of Obesity (2005)
|
September 16, 2009
Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C
M-H Hsieh, C-K Ho, N-J Hou, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 9, 2004
Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma
J F Tsai, J E Jeng, L Y Chuang, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 5, 2014
Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant
H-H Hsiao, Y-C Liu, H-C Wang, et al.
Alimentary Pharmacology & Therapeutics
|
May 26, 2018
Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience
V L Chen, M-L Yeh, A K Le, et al.
ESMO Open
|
August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
M Simonelli, E Garralda, F Eskens, et al.
Hepatology International
|
May 13, 2026
The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease
H Elangovan, K Akbary, A Rastogi, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Alimentary Pharmacology & Therapeutics
|
April 19, 2007
Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan
J-F Huang, M-L Yu, C-M Lee, et al.
Journal of Medical Virology
|
August 16, 2001
Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan
M L Yu, W L Chuang, S C Chen, et al.
The Kaohsiung Journal of Medical Sciences
|
March 29, 2001
The epidemiology of TT virus (TTV) infection in a hepatitis C and B virus hyperendemic area of southern Taiwan
C Y Dai, M L Yu, W L Chuang, et al.
International Journal of Obesity (2005)
|
September 16, 2009
Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C
M-H Hsieh, C-K Ho, N-J Hou, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 9, 2004
Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma
J F Tsai, J E Jeng, L Y Chuang, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 5, 2014
Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant
H-H Hsiao, Y-C Liu, H-C Wang, et al.
Alimentary Pharmacology & Therapeutics
|
May 26, 2018
Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience
V L Chen, M-L Yeh, A K Le, et al.
ESMO Open
|
August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
M Simonelli, E Garralda, F Eskens, et al.
Hepatology International
|
May 13, 2026
The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease
H Elangovan, K Akbary, A Rastogi, et al.
Page
of 10